CD47 is broadly expressed on normal cells but is frequently upregulated in cancer, including hematologic malignancies and solid tumors, where it engages signal regulatory protein alpha (SIRPα) on macrophages and dendritic cells (DCs) [3,4]. Here, SIRPA is linked to hematologic disorder.